Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cryoport (CYRX) EBT (2016 - 2025)

Cryoport (CYRX) has disclosed EBT for 14 consecutive years, with -$7.4 million as the latest value for Q4 2025.

  • On a quarterly basis, EBT rose 57.27% to -$7.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$32.2 million, a 69.17% increase, with the full-year FY2025 number at -$32.2 million, up 69.17% from a year prior.
  • EBT was -$7.4 million for Q4 2025 at Cryoport, down from -$4.2 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $4.2 million in Q3 2024 to a low of -$261.0 million in Q4 2021.
  • A 5-year average of -$26.5 million and a median of -$8.8 million in 2022 define the central range for EBT.
  • Peak YoY movement for EBT: plummeted 2144.19% in 2021, then soared 133.1% in 2024.
  • Cryoport's EBT stood at -$261.0 million in 2021, then surged by 96.95% to -$8.0 million in 2022, then crashed by 510.81% to -$48.6 million in 2023, then skyrocketed by 64.4% to -$17.3 million in 2024, then surged by 57.27% to -$7.4 million in 2025.
  • Per Business Quant, the three most recent readings for CYRX's EBT are -$7.4 million (Q4 2025), -$4.2 million (Q3 2025), and -$11.7 million (Q2 2025).